Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results.

Posted on January 29th, 2008 by Tom

Related Articles

Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results.
Neurosurgery. 2007 Nov;61(5):1031-7; discussioin 1037-8
Authors: Vogelbaum MA, Sampson JH, Kunwar S, Chang SM, Shaffrey M, Asher AL, Lang FF, Croteau D, Parker K, Grahn AY, Sherman JW, […]

Filed under: radiation | No Comments »

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.

Posted on January 28th, 2008 by Tom

Related Articles

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.
Br J Cancer. 2007 Aug 6;97(3):302-7
Authors: Mauer M, Stupp R, Taphoorn MJ, Coens C, Osoba D, Marosi C, Wong […]

Filed under: radiation | No Comments »

« Previous Page — Next Page »

 

Advertise here for free